Unknown

Dataset Information

0

Prognostic Value of Serum Caspase-Cleaved Cytokeratin-18 Levels before Liver Transplantation for One-Year Survival of Patients with Hepatocellular Carcinoma.


ABSTRACT: Cytokeratin (CK)-18 is the major intermediate filament protein in the liver and during hepatocyte apoptosis is cleaved by the action of caspases; the resulting fragments are released into the blood as caspase-cleaved cytokeratin (CCCK)-18. Higher circulating levels of CCCK-18 have been found in patients with hepatocellular carcinoma (HCC) than in healthy controls and than in cirrhotic patients. However, it is unknown whether serum CCCK-18 levels before liver transplantation (LT) in patients with HCC could be used as a prognostic biomarker of one-year survival, and this was the objective of our study with 135 patients. At one year after LT, non-survivors showed higher serum CCCK-18 levels than survivors (p = 0.001). On binary logistic regression analysis, serum CCCK-18 levels >384 U/L were associated with death at one year (odds ratio = 19.801; 95% confidence interval = 5.301-73.972; p < 0.001) after controlling for deceased donor age. The area under the receiver operating characteristic (ROC) curve of serum CCCK-18 levels to predict death at one year was 77% (95% CI = 69%-84%; p < 0.001). The new finding of our study was that serum levels of CCCK-18 before LT in patients with HCC could be used as prognostic biomarker of survival.

SUBMITTER: Lorente L 

PROVIDER: S-EPMC5037799 | biostudies-literature | 2016 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Prognostic Value of Serum Caspase-Cleaved Cytokeratin-18 Levels before Liver Transplantation for One-Year Survival of Patients with Hepatocellular Carcinoma.

Lorente Leonardo L   Rodriguez Sergio T ST   Sanz Pablo P   Pérez-Cejas Antonia A   Padilla Javier J   Díaz Dácil D   González Antonio A   Martín María M MM   Jiménez Alejandro A   Barrera Manuel A MA  

International journal of molecular sciences 20160909 9


Cytokeratin (CK)-18 is the major intermediate filament protein in the liver and during hepatocyte apoptosis is cleaved by the action of caspases; the resulting fragments are released into the blood as caspase-cleaved cytokeratin (CCCK)-18. Higher circulating levels of CCCK-18 have been found in patients with hepatocellular carcinoma (HCC) than in healthy controls and than in cirrhotic patients. However, it is unknown whether serum CCCK-18 levels before liver transplantation (LT) in patients with  ...[more]

Similar Datasets

| S-EPMC5560566 | biostudies-other
| S-EPMC8002276 | biostudies-literature
| S-EPMC9140190 | biostudies-literature
| S-EPMC6775513 | biostudies-other
| S-EPMC5775922 | biostudies-literature
| S-EPMC6560824 | biostudies-other
| PRJEB20258 | ENA
| S-EPMC5994131 | biostudies-literature
| S-EPMC9213077 | biostudies-literature
| S-EPMC10792117 | biostudies-literature